BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1481872)

  • 21. Urinary deoxypyridinoline excretion for the evaluation of bone turnover in chronic renal failure.
    Coen G; Mantella D; Calabria S; Sardella D; Manni M; Fassino V; D'Anello E; Giustini M; Taggi F
    Am J Nephrol; 2000; 20(4):283-90. PubMed ID: 10970981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
    Mazzaferro S; Chicca S; Pasquali M; Zaraca F; Ballanti P; Taggi F; Coen G; Cinotti GA; Carboni M
    Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.
    Magnusson P; Sharp CA; Magnusson M; Risteli J; Davie MW; Larsson L
    Kidney Int; 2001 Jul; 60(1):257-65. PubMed ID: 11422759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
    Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
    Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.
    Salam S; Gallagher O; Gossiel F; Paggiosi M; Khwaja A; Eastell R
    J Am Soc Nephrol; 2018 May; 29(5):1557-1565. PubMed ID: 29555831
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating biochemical markers of bone remodeling in uremic patients.
    Ureña P; De Vernejoul MC
    Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical parameters of bone turnover in kidney transplant recipients.
    Smalcelj R; Kusec V; Puretić Z; Mareković Z
    Wien Klin Wochenschr; 1998 May; 110(9):326-30. PubMed ID: 9629624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone.
    Joffe P; Heaf JG; Jensen LT
    Nephrol Dial Transplant; 1995 Oct; 10(10):1912-7. PubMed ID: 8592603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone histomorphometry in celiac disease.
    Arnala I; Kemppainen T; Kröger H; Janatuinen E; Alhava EM
    Ann Chir Gynaecol; 2001; 90(2):100-4. PubMed ID: 11459257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.
    Gram J; Junker P; Nielsen HK; Bollerslev J
    Bone; 1998 Sep; 23(3):297-302. PubMed ID: 9737353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procollagen type 1 C-terminal extension peptide, PTH and 1,25 (OH) 2D3 in chronic renal failure.
    Coen G; Ballanti P; Mazzaferro S; Pasquali M; Bonucci E
    Bone; 1993; 14(3):415-20. PubMed ID: 8161367
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
    Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
    Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.
    van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM
    Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
    Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological markers in the diagnosis of the different forms of renal osteodystrophy.
    Ferreira A; Drüeke TB
    Am J Med Sci; 2000 Aug; 320(2):85-9. PubMed ID: 10981481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low serum levels of intact osteocalcin in patients with congestive heart failure.
    Schleithoff SS; Zittermann A; Stüttgen B; Tenderich G; Berthold HK; Körfer R; Stehle P
    J Bone Miner Metab; 2003; 21(4):247-52. PubMed ID: 12811631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.